drug
ivabradine hydrochloride
Marketedupdated 5mo agoby Ingenus Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 22, 2026
11 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (20)
- Jun 12, 2027patentUS 7867996*PED244d
- Jun 12, 2027patentUS 7867996*PED244d
- Dec 12, 2026compositionUS 786799662d
- Dec 12, 2026compositionUS 786799662d
- Dec 12, 2026compositionUS 786799662d
- Aug 22, 2026patentUS 7361649*PED
- Aug 22, 2026patentUS 7361649*PED
- Aug 22, 2026patentUS 7361650*PED
- Aug 22, 2026patentUS 7361650*PED
- Aug 22, 2026patentUS 7879842*PED
- Aug 22, 2026patentUS 7879842*PED
- Feb 22, 2026compositionUS 7361649
- Feb 22, 2026compositionUS 7361649
- Feb 22, 2026compositionUS 7361649
- Feb 22, 2026compositionUS 7361650
- Feb 22, 2026compositionUS 7361650
- Feb 22, 2026compositionUS 7361650
- Feb 22, 2026compositionUS 7879842
- Feb 22, 2026compositionUS 7879842
- Feb 22, 2026compositionUS 7879842
FDA exclusivities (2)
- Oct 22, 2026PEDPediatric (6mo bonus)11d
- Apr 22, 2026ODE-234Orphan Drug (7y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that